This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts Love MetLife for 2014

Following MetLlife CFO John Hele's disclosure on Thursday that its fourth-quarter earnings would be affected by "a fourth-quarter litigation asbestos reserve charge of $100 million to $120 million after-tax," Kinar reiterated his "buy" rating for MetLife and price target of $59, while leaving his earnings estimates for 2014 and 2015 unchanged.

What About Buybacks?

In a note to clients late Thursday, Yaron wrote, "based on our current earnings estimates, the company should generate roughly $800mm of incremental capital in '14 and another $1.3 bil increase in '15, for a total of nearly $6 bil ($5.30/ps) over the next two years."

Investors are wondering when some of MetLife's excess capital might be deployed.  The company pays a quarterly dividend of 27.5 cents a share, for a yield of 2.15%.  However, MetLife hasn't been buying back common shares.

MetLife CEO Steven Kandarian during the presentation on Thursday said the firm's return on equity target for 2016 "assumes that regulatory capital rules appropriately reflect the life insurance business model and that we have clarity in the rules and a reasonable timeframe, allowing for meaningful share repurchases prior to 2016."

"Regulatory uncertainty remains our primary challenge, a view that we have consistently expressed to investors," Kandarian added.  MetLife has said previously that it won't announce share repurchase plans until it receives greater clarification from regulators on whether or not it will be treated as a non-bank systemically important financial institution (SIFI).  Under that scenario MetLife's annual plans to deploy capital would be reviewed by the Federal Reserve.

"We are hopeful that we will be able to get things resolved on the regulatory front before the end of 2016, and that we will be able to do some share repurchases. But at this point in time, I really can't commit to what that number will be because we don't know the outcome yet of our potential non-bank SIFI designation," Kandarian said.  He also said the company wouldn't repurchase any shares during 2014.

Love From Other Analysts

"We are maintaining our $5.81 2014 operating EPS estimate. In addition, we are increasing our target price to $57 from $55 on the basis of higher expected core EPS results," Credit Suisse analyst Thomas Gallagher wrote in a note to clients on Thursday, following MetLife's presentations.  Gallagher rates MetLife "outperform."

While noting that MetLife didn't provide specific EPS guidance for 2014, Gallagher wrote that "MET's guidance implies about $5.85-$5.95 of operating EPS for 2014."

KBW analyst Jeffrey Schuman also rates MetLife "outperform," with a $57 price target, writing in a note to clients Thursday that he came away from the presentations with "more optimism about our expectation that Group underwriting results should improve in 2014."

With MetLife projecting an increase in expenses during 2014 because of "enterprise initiatives," Schuman lowered his 2014 EPS estimate slightly to $5.77 from $5.80.

MetLife's shares were down slightly in morning trading Friday, to $51.17.

MET Chart
MET data by YCharts

Interested in more on MetLife? See TheStreet Ratings' report card for this stock.


-- Written by Philip van Doorn in Jupiter, Fla.



>Contact by Email.

Philip W. van Doorn is a member of TheStreet's banking and finance team, commenting on industry and regulatory trends. He previously served as the senior analyst for TheStreet.com Ratings, responsible for assigning financial strength ratings to banks and savings and loan institutions. Mr. van Doorn previously served as a loan operations officer at Riverside National Bank in Fort Pierce, Fla., and as a credit analyst at the Federal Home Loan Bank of New York, where he monitored banks in New York, New Jersey and Puerto Rico. Mr. van Doorn has additional experience in the mutual fund and computer software industries. He holds a bachelor of science in business administration from Long Island University.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs